1. A Phase Ib Study of Single‐Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. (18th June 2020) Authors: Borazanci, Erkut; Pishvaian, Michael J.; Nemunaitis, John; Weekes, Colin; Huang, Julie; Rajakumaraswamy, Nishanthan Journal: Oncologist Issue: Volume 25:Number 11(2020) Page Start: e1604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A regulatory perspective of clinical trial applications for biological products with particular emphasis on Advanced Therapy Medicinal Products (ATMPs). (23rd July 2013) Authors: Jones, David R.; McBlane, James W.; McNaughton, Graham; Rajakumaraswamy, Nishanthan; Wydenbach, Kirsty Journal: British journal of clinical pharmacology Issue: Volume 76:Number 2(2013:Aug.) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO‐idel). (14th June 2021) Authors: Eyre, Toby A.; Preston, Gavin; Kagdi, Huseini; Islam, Amin; Nicholson, Toby; Smith, Harry W.; Cursley, Adam P.; Ramroth, Heribert; Xing, Guan; Gu, Lin; Rajakumaraswamy, Nishanthan; Fegan, Christopher Journal: British journal of haematology Issue: Volume 194:Number 1(2021) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Issue 4 (8th April 2022) Authors: Kutsch, Nadine; Pallasch, Christian; Tausch, Eugen; Böhme, Volkmar; Ritgen, Matthias; Liersch, Rüdiger; Wacker, Alexander; Jacobs, Georg; Trappe, Ralf Ulrich; Dreger, Peter; Fischer, Kirsten; Fink, Anna-Maria; Stilgenbauer, Stephan; Zhai, Shuyan; Li, Biao; Jürgensmeier, Juliane M.; Rajakumaraswam... Journal: HemaSphere Issue: Volume 6:Issue 4(2022) Page Start: e692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Issue 6 (25th June 2022) Authors: Kutsch, Nadine; Pallasch, Christian; Decker, Thomas; Hebart, Holger; Chow, Kai Uwe; Graeven, Ullrich; Kisro, Jens; Kroeber, Alexander; Tausch, Eugen; Fischer, Kirsten; Fink, Anna-Maria; Wendtner, Clemens-Martin; Ritgen, Matthias; Stilgenbauer, Stephan; Zhang, Danjie; Li, Biao; Jürgensmeier, Julia... Journal: HemaSphere Issue: Volume 6:Issue 6(2022) Page Start: e729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Idelalisib immune-related toxicity is associated with improved treatment response. Issue 12 (15th October 2021) Authors: Wagner-Johnston, Nina D.; Sharman, Jeff; Furman, Richard R.; Salles, Gilles; Brown, Jennifer R.; Robak, Tadeusz; Gu, Lin; Xing, Guan; Chan, Rebecca J.; Rajakumaraswamy, Nishanthan; Gopal, Ajay K. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 12(2021) Page Start: 2915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas. Issue 5 (16th April 2021) Authors: Wagner-Johnston, Nina D.; Schuster, Stephen J.; deVos, Sven; Salles, Gilles; Jurczak, Wojciech J.; Flowers, Christopher R.; Viardot, Andreas; Flinn, Ian W.; Martin, Peter; Xing, Guan; Rajakumaraswamy, Nishanthan; Gopal, Ajay K. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 5(2021) Page Start: 1077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗